サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1468293

ワクチンデリバリーデバイス市場レポート：デバイス、投与経路、エンドユーザー、地域別、2024～2032年

Vaccine Delivery Devices Market Report by Device, Route of Administration, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 138 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ワクチンデリバリーデバイス市場レポート：デバイス、投与経路、エンドユーザー、地域別、2024～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のワクチンデリバリーデバイス市場規模は2023年に75億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに135億米ドルに達し、2024～2032年の間に6.61%の成長率（CAGR）を示すと予測しています。

ワクチンは、細菌性疾患に対する身体の免疫反応を刺激することにより、細菌性疾患から個人を保護するために使用される生物学的物質です。特定の間隔で投与することにより、免疫系が侵入抗原に対する抗体を産生するのを助ける。リポソーム、ミクロスフェア、ナノ粒子、デンドリマー、ミセル化システム、免疫刺激複合体（ISCOM）、植物由来のウイルスなどを通して体内に投与することができます。現在、世界中で感染症が流行しているため、ワクチンデリバリーデバイスの利用が増加しています。

ワクチンデリバリーデバイスの市場動向：

マイクロニードルやエレクトロポレーションなど、ワクチンの体系的デリバリーにおける技術的進歩は、市場を牽引する重要な要因の1つです。さらに、針刺し傷害の減少やワクチン抗原投与量の減少、ワクチン免疫原性の向上から、針を使用しないデリバリーシステムの利用が増加しています。このことは、ワクチンセグメントにおける研究の高まりや、世界中で新しいワクチンデリバリーデバイスが開発されていることと共に、市場の成長を後押ししています。さらに、ワクチンで予防可能な疾病による障害や死亡を予防するため、各国政府は予防接種プログラムを推進しています。これと相まって、非政府組織（NGO）による様々な予防接種プログラムやキャンペーンへの投資が世界的に拡大しており、市場にプラスの影響を与えています。このほか、主要市場参入企業は、毒性を低減することでワクチンの治療価値を高める新規デリバリー技術に注力しています。さらに、高齢者人口の増加による医療セグメントの拡大と、医療製品やサービスへの容易なアクセスが、市場の成長を後押ししています。さらに、コロナウイルス病（COVID-19）の発生は、ワクチンデリバリーデバイスの世界の売上を増強しています。

本レポートで扱う主要質問

  • 2023年の世界のワクチンデリバリーデバイス市場規模は？
  • 2024～2032年の世界のワクチンデリバリーデバイス市場の予想成長率は？
  • ワクチンデリバリーデバイスの世界市場を牽引する主要因は？
  • COVID-19が世界のワクチンデリバリーデバイス市場に与えた影響は？
  • デバイス別の世界のワクチンデリバリーデバイス市場の内訳は？
  • 投与経路別のワクチンデリバリーデバイス世界市場の内訳は？
  • 世界のワクチンデリバリーデバイス市場のエンドユーザー別の区分は？
  • ワクチンデリバリーデバイスの世界市場における主要地域は？
  • 世界のワクチンデリバリーデバイス市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 ワクチンデリバリーデバイスの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：デバイス別

  • 注射器
  • ジェットインジェクター
  • その他

第7章 市場内訳：投与経路別

  • 筋肉内接種
  • 皮内接種
  • 皮下ワクチン接種
  • その他

第8章 市場内訳：エンドユーザー別

  • 病院
  • クリニック
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • 3M Company
    • Becton Dickinson and Company
    • Enesi Pharma Limited
    • Gerresheimer AG
    • INOVIO Pharmaceuticals
    • NanoPass
    • Panacea Biotec Pharma Limited（Panacea Biotec）
    • Pharmajet Inc.
    • Schott AG（Carl-Zeiss-Stiftung）
    • Terumo Corporation
    • Vaxxas
図表

List of Figures

  • Figure 1: Global: Vaccine Delivery Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Vaccine Delivery Devices Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Vaccine Delivery Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Vaccine Delivery Devices Market: Breakup by Device (in %), 2023
  • Figure 5: Global: Vaccine Delivery Devices Market: Breakup by Route of Administration (in %), 2023
  • Figure 6: Global: Vaccine Delivery Devices Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Vaccine Delivery Devices Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Vaccine Delivery Devices (Syringes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Vaccine Delivery Devices (Syringes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Vaccine Delivery Devices (Jet Injectors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Vaccine Delivery Devices (Jet Injectors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Vaccine Delivery Devices (Other Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Vaccine Delivery Devices (Other Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Vaccine Delivery Devices (Intramuscular Vaccination) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Vaccine Delivery Devices (Intramuscular Vaccination) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Vaccine Delivery Devices (Intradermal Vaccination) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Vaccine Delivery Devices (Intradermal Vaccination) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Vaccine Delivery Devices (Subcutaneous Vaccination) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Vaccine Delivery Devices (Subcutaneous Vaccination) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Vaccine Delivery Devices (Other Routes of Administration) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Vaccine Delivery Devices (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Vaccine Delivery Devices (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Vaccine Delivery Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Vaccine Delivery Devices (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Vaccine Delivery Devices (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Vaccine Delivery Devices (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Vaccine Delivery Devices (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Vaccine Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Vaccine Delivery Devices Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Vaccine Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Vaccine Delivery Devices Industry: SWOT Analysis
  • Figure 78: Global: Vaccine Delivery Devices Industry: Value Chain Analysis
  • Figure 79: Global: Vaccine Delivery Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Vaccine Delivery Devices Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Vaccine Delivery Devices Market Forecast: Breakup by Device (in Million US$), 2024-2032
  • Table 3: Global: Vaccine Delivery Devices Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 4: Global: Vaccine Delivery Devices Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Vaccine Delivery Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Vaccine Delivery Devices Market: Competitive Structure
  • Table 7: Global: Vaccine Delivery Devices Market: Key Players
目次
Product Code: SR112024A5933

The global vaccine delivery devices market size reached US$ 7.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.61% during 2024-2032.

A vaccine is a biological substance used to protect individuals from bacterial illnesses by stimulating the immune response of the body against the disease. It helps the immune system to produce antibodies against the invading antigens when given at specific intervals. It can be delivered in the body through liposomes, microspheres, nanoparticles, dendrimers, micellar systems, immune stimulating complexes (ISCOMs), and plant-derived viruses. At present, there is a rise in the utilization of vaccine delivery devices due to the growing prevalence of infectious diseases across the globe.

Vaccine Delivery Devices Market Trends:

Technological advancements in the systematic delivery of vaccines, such as micro-needles and electroporation, represent one of the key factors driving the market. Moreover, there is an increase in the utilization of needle-free delivery systems as they decrease needle stick injuries and the vaccine antigen dose and enhance the vaccine immunogenicity. This, along with the rising research in the field of vaccines and the development of new vaccine delivery devices around the world, is propelling the growth of the market. In addition, governments of several countries are promoting immunization programs to prevent disabilities and deaths from vaccine-preventable diseases. This, coupled with the growing investments by non-governmental organizations (NGOs) for various vaccination programs and campaigns globally, is positively influencing the market. Besides this, key market players are focusing on novel delivery technologies that increase the therapeutic value of vaccines by reducing toxicity. Additionally, the expanding healthcare sector due to the increasing geriatric population and easy access to medical products and services is bolstering the market growth. Furthermore, the outbreak of coronavirus disease (COVID-19) is augmenting the sales of vaccine delivery devices worldwide.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global vaccine delivery devices market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on device, route of administration and end user.

Breakup by Device:

Syringes

Jet Injectors

Others

Breakup by Route of Administration:

Intramuscular Vaccination

Intradermal Vaccination

Subcutaneous Vaccination

Others

Breakup by End User:

Hospitals

Clinics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Becton Dickinson and Company, Enesi Pharma Limited, Gerresheimer AG, INOVIO Pharmaceuticals, NanoPass, Panacea Biotec Pharma Limited (Panacea Biotec), Pharmajet Inc., Schott AG (Carl-Zeiss-Stiftung), Terumo Corporation and Vaxxas.

Key Questions Answered in This Report

  • 1. What was the size of the global vaccine delivery devices market in 2023?
  • 2. What is the expected growth rate of the global vaccine delivery devices market during 2024-2032?
  • 3. What are the key factors driving the global vaccine delivery devices market?
  • 4. What has been the impact of COVID-19 on the global vaccine delivery devices market?
  • 5. What is the breakup of the global vaccine delivery devices market based on the device?
  • 6. What is the breakup of the global vaccine delivery devices market based on the route of administration?
  • 7. What is the breakup of the global vaccine delivery devices market based on end user?
  • 8. What are the key regions in the global vaccine delivery devices market?
  • 9. Who are the key players/companies in the global vaccine delivery devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Vaccine Delivery Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Device

  • 6.1 Syringes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Jet Injectors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Intramuscular Vaccination
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Intradermal Vaccination
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Subcutaneous Vaccination
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Enesi Pharma Limited
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Gerresheimer AG
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 INOVIO Pharmaceuticals
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 NanoPass
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Panacea Biotec Pharma Limited (Panacea Biotec)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Pharmajet Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Schott AG (Carl-Zeiss-Stiftung)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Terumo Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Vaxxas
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio